Specific to LN, Zhao and colleagues demonstrated that TWEAK plays an important role in the murine chronic graft versus host model of LN, such that Fn14-knockout mice, or mice treated with anti-TWEAK monoclonal antibodies, exhibited reduced inflammation and less severe nephritis [24]. The gene discussed is TNFSF12; the disease is nephritis.